申请人:UTI LIMITED PARTNERSHIP
公开号:US20160367700A1
公开(公告)日:2016-12-22
The present application provides an amphiphilic cyclodextrin-based compound of the formula I: R-G-D-A (I) wherein R is one or more hydrophilic groups; G is one or more linkers; D is a cyclodextrin, and A is one or more aliphatic groups. In certain embodiments, the hydrophilic group is a sugar such as lactose, the linker comprises —(CHR′CH
2
O)
n
— where R′ is H or is an alkyl group substituted with —(CHR′CH
2
O)
n
— where n is 1 to 20, typically n=4; the cyclodextrin is a β-cyclodextrin comprising 7 subunits, and the aliphatic groups are C
6
alkyl groups. The compound can be used to enhance water solubility, bioavailability, cellular uptakes of active ingredients used in medicines, cosmetics and foods and other products, for detection, removal and immobilization of pathogenic organisms, toxins, and autoantibodies, and biomarkers on solid matrix, or for molecular biological techniques, such as ELISA, for example.
本申请提供了一种基于环糊精的两性分子化合物,其化学式为I:R-G-D-A(I),其中R是一个或多个亲水基团;G是一个或多个连接基团;D是一个环糊精;A是一个或多个脂肪族基团。在某些实施例中,亲水基团是一种糖,如乳糖;连接基团包括—(CHR′CH2O)n—,其中R′是H或被—(CHR′CH2O)n—取代的烷基,其中n为1至20,通常n=4;环糊精是由7个亚基组成的β-环糊精,脂肪族基团是C6烷基。该化合物可用于增强药品、化妆品和食品等产品中使用的活性成分的水溶性、生物利用度和细胞摄取,用于检测、去除和固定病原体、毒素和自身抗体以及固定在固体基质上的生物标志物,或用于分子生物学技术,例如ELISA。